Market Overview The hyperuricemia drugs market is expanding significantly as metabolic disorder treatment evolves and chronic disease management integrates. The Hyperuricemia Drugs Market is projected to exceed USD 8.0 billion through 2035, driven by metabolic syndrome epidemic, chronic kidney disease association, and cardiovascular risk awareness. Hyperuricemia drugs market enable...